Peer support community for people with neuroendocrine cervical cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational program enrolls adults with histologically confirmed neuroendocrine cervical cancer who can use a computer or smartphone; participants join a technology-based peer support community and complete questionnaires about their experiences. The primary aim is to see if participation changes illness perception, emotional wellbeing, and feelings of isolation. Secondary aims include understanding effects on communication with healthcare providers, coping strategies, acceptability of the support format, and identifying unmet needs. Data are collected via questionnaires without any drug or device intervention.

Why it matters

Who can join: the full rules

Eligibility Criteria

* Histologically confirmed NECC.
* Aged 18 years or older.
* English proficient.
* Provision of signed and dated informed consent form.
* Stated willingness to comply with all study procedures and availability for the duration of the study.
* Access to necessary resources for participating in a technology-based intervention (i.e., computer, smartphone, internet access).

Exclusion Criteria None

Where it's running

• MD Anderson Cancer Center
  Houston, Texas, United States Recruiting

Study contacts

• Principal investigator: Larissa Meyer, MD — M.D. Anderson Cancer Center
• Study coordinator: Larissa Meyer, MD
• Email: lmeyer@mdanderson.org
• Phone: Meyer

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Preventing heart problems in overweight/obese young sarcoma survivors with tirzepatide

  This feasibility study tests whether tirzepatide can be safely given to overweight or obese young adults (18–39) who have completed doxorubicin for soft tissue or bone sarcoma to see if it’s feasible to use in the first year after therapy.

  Recruiting Phase 2 M.D. Anderson Cancer Center · Houston, Texas · NCT07874828

• Predicting lymphedema risk in inflammatory breast cancer patients using preoperative body impedance analysis

  This study tests whether a preoperative bioimpedance test can help identify IBC patients who are at risk for developing lymphedema.

  Recruiting M.D. Anderson Cancer Center · Houston, Texas · NCT07855627

• Precision genomic testing to guide first-line LBCL treatment readiness

  Doctors will see if a tumor genomic test can help tailor first-line treatment for adults with LBCL by the start of the second cycle of standard therapy.

  Recruiting M.D. Anderson Cancer Center · Houston, Texas · NCT07829445

• Using Apple Vision Pro in image-guided procedures

  This study tests whether the Apple Vision Pro can be used during CT-guided biopsy procedures to help with imaging and guidance.

  Recruiting M.D. Anderson Cancer Center · Houston, Texas · NCT07819513

• Geniculate Artery Embolization for Knee Osteoarthritis in Cancer Patients

  This study tests whether blocking knee blood vessels with a standard care procedure can help reduce pain and improve function in people with knee osteoarthritis who also have cancer.

  Recruiting M.D. Anderson Cancer Center · Houston, Texas · NCT07807943

• Urothelial Carcinoma Biospecimen Collection and Data Study

  This project tests collecting and storing tissue, blood, and imaging data from adults with urothelial carcinoma to support translational research.

  Recruiting M.D. Anderson Cancer Center · Houston, Texas · NCT07789119

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.